News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,262 Results
Type
Article (87389)
Company Profile (759)
Press Release (772088)
Multimedia
Podcasts (169)
Webinars (27)
Section
Business (233038)
Career Advice (4137)
Deals (39790)
Drug Delivery (134)
Drug Development (91241)
Employer Resources (202)
FDA (18275)
Job Trends (17396)
News (397350)
Policy (39924)
Tag
Academia (3004)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (143)
Alzheimer's disease (1678)
Antibody-drug conjugate (ADC) (228)
Approvals (18287)
Artificial intelligence (482)
Autoimmune disease (68)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (480)
Cancer (3810)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (242)
CDC (56)
Cell therapy (673)
Cervical cancer (32)
Clinical research (75301)
Collaboration (1363)
Company closure (4)
Compensation (929)
Complete response letters (59)
COVID-19 (2951)
CRISPR (81)
C-suite (570)
Cystic fibrosis (133)
Data (4265)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (445)
Diagnostics (7085)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (229)
Drug pricing (186)
Drug shortages (36)
Duchenne muscular dystrophy (201)
Earnings (98749)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132819)
Executive appointments (981)
FDA (20685)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (1229)
Gene editing (173)
Generative AI (47)
Gene therapy (540)
GLP-1 (1012)
Government (5378)
Grass and pollen (7)
Guidances (337)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (52)
Infectious disease (3184)
Inflammatory bowel disease (185)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (184)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (638)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (544)
Lymphoma (259)
Machine learning (29)
Management (66)
Manufacturing (630)
MASH (136)
Medical device (14858)
Medtech (14879)
Mergers & acquisitions (22731)
Metabolic disorders (1138)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (225)
Neuropsychiatric disorders (59)
Neuroscience (2698)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (554)
Opinion (310)
Ovarian cancer (124)
Pain (161)
Pancreatic cancer (166)
Parkinson's disease (239)
Partnered (30)
Patents (411)
Patient recruitment (298)
Peanut (57)
People (66222)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23220)
Phase II (32700)
Phase III (24596)
Pipeline (2657)
Policy (294)
Postmarket research (3554)
Preclinical (10481)
Press Release (72)
Prostate cancer (192)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (657)
Real estate (7421)
Recruiting (78)
Regulatory (27944)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (205)
Series B (150)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (93)
The Weekly (107)
Vaccines (1037)
Venture capital (66)
Weight loss (391)
Women's health (58)
Worklife (21)
Date
Today (111)
Last 7 days (555)
Last 30 days (2401)
Last 365 days (33571)
2025 (25801)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50918)
Australia (8952)
California (9326)
Canada (2826)
China (878)
Colorado (397)
Connecticut (417)
Delaware (260)
Europe (117016)
Florida (1370)
Georgia (312)
Hawaii (3)
Idaho (67)
Illinois (805)
India (50)
Indiana (455)
Iowa (19)
Japan (311)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1263)
Massachusetts (7013)
Michigan (308)
Minnesota (559)
Mississippi (4)
Missouri (118)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2574)
New Mexico (32)
New York (2543)
North Carolina (1400)
North Dakota (10)
Northern California (4198)
Ohio (293)
Oklahoma (21)
Oregon (50)
Pennsylvania (1942)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (47)
South Dakota (1)
Southern California (3564)
Tennessee (149)
Texas (1463)
United States (34502)
Utah (276)
Virginia (246)
Washington D.C. (83)
Washington State (805)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,262 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
Nabla and Takeda first joined hands in 2022, to push “the boundaries of next-generation biologics discovery,” according to the startup’s CEO Surge Biswas.
October 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
October 14, 2025
·
14 min read
Press Releases
AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939
October 14, 2025
·
8 min read
Press Releases
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
October 14, 2025
·
8 min read
Press Releases
Avanzanite Expands Italian Operations with General Manager Appointment
October 14, 2025
·
3 min read
Press Releases
Iksuda to Present IKS014 Phase 1 Data at ESMO
October 14, 2025
·
2 min read
Press Releases
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 14, 2025
·
3 min read
Press Releases
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
October 14, 2025
·
4 min read
Press Releases
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
October 14, 2025
·
7 min read
Press Releases
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
October 14, 2025
·
4 min read
1 of 86,027
Next
